The Journal of Immunology · 2005 · 79 citations · 37 references
Life SciencesImmunologyMolecular BiologyCell SignalingMolecular Cell BiologySignal TransductionB Cell ActivationB Cell BiologyB Cell Receptor SignalingB-cell ResponsesCell-surface ReceptorsHumoral ImmunityActivationB Cell Receptor ActivationB Cell Receptor PhosphorylationB Cell Receptor RecognitionCell ActivationComplement ReceptorsSrc Homology 2 DomainsTransgenic Mice
C3dg is a cleavage product of the C3 component of complement that can facilitate the coligation of the complement receptor 2 (CR2/CD21) with the BCR via C3dg/Ag complexes. This interaction can greatly amplify BCR-mediated signaling events and acts to lower the threshold for B cell activation. Although previous studies have used anti-CR2 Abs or used chimeric Ags in the context of BCR transgenic mice as surrogate C3d-containing ligands, we have used a physiological form of C3d to study signaling in B cells from wild-type C57BL/6 mice. We find that while CR2-enhanced BCR signaling causes intracellular Ca2+ mobilization and total pTyr phosphorylation of an intensity comparable to optimal BCR ligation using anti-IgM Abs, it does so with limited activation of inhibitory effectors (such as CD22, Src homology region 2 domain containing phosphatase 1, and SHIP-1) and without substantial receptor cross-linking. In summary, we demonstrate that CR2-enhanced BCR signaling may proceed not only through the previously described amplification of positive signaling pathways, but is potentially augmented by a lack of normal inhibitory/feedback signaling.
37
C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity
Paul W. Dempsey, Michael Allison, Srinivas Akkaraju et al. · Science · 1996 · 1.2K citations
CD22 is a negative regulator of B-cell receptor signalling
Lars Nitschke, Rita Carsetti, Bettina Ocker et al. · Current Biology · 1997 · 441 citations · Full text